Literature DB >> 28656388

Indications and outcomes for tunneled central venous line placement via the axillary vein in children.

Allison F Linden1,2, Chase Corvin3, Keva Garg3, Richard R Ricketts4, A Alfred Chahine5,6.   

Abstract

PURPOSE: To assess the indications, safety and outcomes of tunneled central venous catheters (CVCs) placed via a cutdown approach into the axillary vein in children, an approach not well described in this population.
METHODS: A retrospective cohort study was performed on pediatric patients who received CVCs via open cannulation of the axillary vein or one of its tributaries between January 2006 and October 2016 at two hospitals.
RESULTS: A total of 24 axillary CVCs were placed in 20 patients [10 male (42%); mean weight 7.0 kg (SD 2.9); mean age 10 months (SD 6)]. The most common indications for axillary vein access included neck or chest wall challenges (tracheostomies or chest wall wounds) (n = 18). The median duration of line placement was 140 days (IQR 146). The most common indications for removal were completion of therapy (n = 7, 39%) and infection (n = 5, 28%). There were no early complications. Long-term complications included infection (n = 5) or catheter malfunction (n = 3).
CONCLUSIONS: Tunneled CVC placement via a cutdown approach into the axillary vein or its tributary can be an effective alternative approach to obtain long-term vascular access in children. Outcomes may be comparable to lines placed in traditional internal jugular and subclavian vein locations.

Entities:  

Keywords:  Axillary vein; Central venous line placement

Mesh:

Year:  2017        PMID: 28656388     DOI: 10.1007/s00383-017-4099-y

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  21 in total

1.  Transpectoral ultrasound-guided catheterization of the axillary vein: an alternative to standard catheterization of the subclavian vein.

Authors:  Navparkash S Sandhu
Journal:  Anesth Analg       Date:  2004-07       Impact factor: 5.108

Review 2.  Complications of Central Venous Access Devices: A Systematic Review.

Authors:  Amanda J Ullman; Nicole Marsh; Gabor Mihala; Marie Cooke; Claire M Rickard
Journal:  Pediatrics       Date:  2015-10-12       Impact factor: 7.124

3.  Central venous cannulation using the infraclavicular axillary vein.

Authors:  B L Taylor; I Yellowlees
Journal:  Anesthesiology       Date:  1990-01       Impact factor: 7.892

4.  Peripherally inserted central venous catheters: frequency of complications in premature newborn depends on the insertion site.

Authors:  P Panagiotounakou; G Antonogeorgos; E Gounari; S Papadakis; J Labadaridis; A K Gounaris
Journal:  J Perinatol       Date:  2014-03-13       Impact factor: 2.521

5.  Saphenofemoral venous cutdowns in the premature infant.

Authors:  N B Meland; W Wilson; C Y Soontharotoke; C J Koucky
Journal:  J Pediatr Surg       Date:  1986-04       Impact factor: 2.545

6.  Identifying and reducing early complications of surgical central lines in infants and toddlers.

Authors:  Sara C Fallon; Michael E Kim; Caraciolo J Fernandes; Sanjeev A Vasudevan; Jed G Nuchtern; Eugene S Kim
Journal:  J Surg Res       Date:  2014-04-13       Impact factor: 2.192

7.  Thrombotic complications of saphenous central venous lines.

Authors:  K G Pippus; J M Giacomantonio; D A Gillis; E P Rees
Journal:  J Pediatr Surg       Date:  1994-09       Impact factor: 2.545

Review 8.  Ultrasound-guided vascular access in adults and children: beyond the internal jugular vein puncture.

Authors:  Th Pirotte
Journal:  Acta Anaesthesiol Belg       Date:  2008

9.  Cost-effectiveness of a central venous catheter care bundle.

Authors:  Kate A Halton; David Cook; David L Paterson; Nasia Safdar; Nicholas Graves
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

10.  Epidemiologic Associations Between Short-Bowel Syndrome and Bloodstream Infection Among Hospitalized Children.

Authors:  Benjamin A Miko; Suma S Kamath; Bevin A Cohen; Christie Jeon; Haomiao Jia; Elaine L Larson
Journal:  J Pediatric Infect Dis Soc       Date:  2014-08-11       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.